УКР ENG

Search:


Email:  
Password:  

 REGISTRATION CERTIFICATE

KV #19905-9705 PR dated 02.04.2013.

 FOUNDERS

RESEARCH CENTRE FOR INDUSTRIAL DEVELOPMENT PROBLEMS of NAS (KHARKIV, UKRAINE)

According to the decision No. 802 of the National Council of Television and Radio Broadcasting of Ukraine dated 14.03.2024, is registered as a subject in the field of print media.
ID R30-03156

 PUBLISHER

Liburkina L. M.

 SITE SECTIONS

Main page

Editorial staff

Editorial policy

Annotated catalogue (2011)

Annotated catalogue (2012)

Annotated catalogue (2013)

Annotated catalogue (2014)

Annotated catalogue (2015)

Annotated catalogue (2016)

Annotated catalogue (2017)

Annotated catalogue (2018)

Annotated catalogue (2019)

Annotated catalogue (2020)

Annotated catalogue (2021)

Annotated catalogue (2022)

Annotated catalogue (2023)

Annotated catalogue (2024)

Thematic sections of the journal

Proceedings of scientific conferences


The USA in the Global Pharmaceutical Market: The Current State and Development Prospects
Shuba M. V., Shtanko A. S.

Shuba, Maryna V., and Shtanko, Anna S. (2023) “The USA in the Global Pharmaceutical Market: The Current State and Development Prospects.” Business Inform 8:23–29.
https://doi.org/10.32983/2222-4459-2023-8-23-29

Section: International Economic Relations

Article is written in Ukrainian
Downloads/views: 1

Download article (pdf) -

UDC 338.4

Abstract:
The article is aimed at defining the current state and prospects of development of the USA in the global pharmaceutical market. It is defined that American pharmaceutical companies successfully conduct their activities in the global pharmaceutical market. The leading pharmaceutical companies of the USA in terms of income and capitalization are considered. It is determined that the United States has a significant role in regulating the global pharmaceutical market. The activities of the U.S. Federal Food and Drug Administration ensure a high level of safety and efficacy of medicines used around the world and increase trust in the U. S. pharmaceutical companies. It is further determined that one of the main features of the USA’s participation in the global pharmaceutical market is the strong position of the U.S. pharmaceutical companies in the market of innovative drugs. The costs of research and development by leading pharmaceutical companies are considered. The indicators of foreign trade in the U.S. pharmaceutical products are analyzed. The U. S. exports account for 9.4% of global pharmaceutical exports, the country ranks fourth in the ranking of world exporters. China, the Netherlands, Canada, Japan, and Germany were the main importers of the U. S. pharmaceutical products in 2022. On the other hand, the United States itself is the main importer of pharmaceutical products. The U. S. imports account for 17.4% of global pharmaceutical imports. Ireland, Germany and Switzerland are major exporters of pharmaceutical products to the United States. The article generalizes the main trends in the pharmaceutical market of the United States, influencing the prospects of their participation in the global pharmaceutical market. It is concluded that the USA has great prospects in the global pharmaceutical market. The country has a strong scientific base and developed infrastructure, which allows the U. S. pharmaceutical companies to be competitive in the global market and ensure sustainable development of the industry. Also, the United States has a large consumer market. It is determined that the United States may experience certain obstacles in the global pharmaceutical market due to the high cost of drug development, as well as high drug prices.

Keywords: global pharmaceutical market, the USA, pharmaceutical products, exports, imports.

Fig.: 6. Tabl.: 1. Bibl.: 18.

Shuba Maryna V. – Candidate of Sciences (Economics), Associate Professor, Associate Professor, Department of International Economic Relations named after Artur Golikov, V. N. Karazin Kharkiv National University (4 Svobody Square, Kharkіv, 61022, Ukraine)
Email: [email protected]
Shtanko Anna S. – Student, V. N. Karazin Kharkiv National University (4 Svobody Square, Kharkіv, 61022, Ukraine)
Email: [email protected]

List of references in article

Banal-Estanol, A., Newham, M., and Seldeslachts, J. “Common Ownership in the U. S. Pharmaceutical Industry: A Network Analysis“. Antitrust Bulletin, vol. 66, no. 1 (2021): 68-99. DOI: https://doi.org/10.1177/0003603X20985796
Daemmrich, A. “U. S. healthcare reform and the pharmaceutical market: Projections from institutional history“. Pharmaceuticals Policy & Law, vol. 15, no. 3/4 (2013): 137-162. DOI: https://doi.org/10.3233/PPL-130367
Petrashko, L., and Mykhailovska, M. “Suchasni tendentsii rozvytku svitovoho farmatsevtychnoho rynku“ [Modern Trends in the Development of the World Pharmaceutical Market]. Topical issues of the development of modern science. Abstracts of the 5th International scientific and practical conference. Sofia, Bulgaria: Publishing House “ACCENT”, 2020. 767-773.
Dorovskoy, A. V. “Segmenty mirovogo farmatsevticheskogo rynka: tendentsii i protivorechiya razvitiya“ [Segments of the World Pharmaceutical Market: Development Trends and Contradictions]. Biznes Inform. 2014. https://www.business-inform.net/export_pdf/business-inform-2014-9_0-pages-34_40.pdf
“U. S. pharmacy market“. https://www.fortunebusinessinsights.com/u-s-pharmacy-market-106306
Joshi, K. “US Pharmaceutical Industry Statistics - By Total Revenue, Region, Value, Job Posting, Total Numbers“. https://www.enterpriseappstoday.com/stats/us-pharmaceutical-industry-statistics.html
Kolmar, Ch. “25+ Incredible U. S. Pharmaceutical Statistics 2023: Facts, Data, Trends and More“. https://www.zippia.com/advice/us-pharmaceutical-statistics/
“Comparing Global Pharmaceutical Markets: US, UK, and China“. https://pharmanewsintel.com/features/comparing-global-pharmaceutical-markets-the-us-uk-and-china
“The top 20 pharma companies by 2022 revenue“. https://www.fiercepharma.com/pharma/top-20-pharma-companies-2022-revenue
“Top 10 Pharmaceutical Companies in the World by Market Capitalization“. https://www.globaldata.com/companies/top-companies-by-sector/healthcare/global-companies-by-market-cap/
“About FDA“. https://www.fda.gov/about-fda
“Research and development expenditure: U.S. pharmaceutical industry 1995-2021“. https://www.statista.com/statistics/265085/research-and-development-expenditure-us-pharmaceutical-industry/
Brown, A., and Elmhirst, E. “Big pharma holds steady on research spending“. https://www.evaluate.com/vantage/articles/insights/other-data/big-pharma-holds-steady-research-spending
“Pharmaceuticals: cost of drug development in the U.S. since 1975“. https://www.statista.com/statistics/265054/pharmaceuticals-cost-of-development-in-the-us/
“Pharmaceutical products. ITC“. https://www.trademap.org/Country_SelProduct_TS.aspx?nvpm=1%7c%7c%7c%7c%7c30%7c%7c%7c2%7c1%7c1%7c3%7c2%7c1%7c2%7c1%7c1%7c1
“The Top 11 Pharma Trends to Watch throughout 2023“. https://www.iqvia.com/locations/united-states/blogs/2022/03/top-11-pharma-trends-to-watch-throughout-2023
“Trends And Estimates For The Pharmaceutical Industry In 2023“. https://www.worldpharmatoday.com/news/trends-and-estimates-for-the-pharmaceutical-industry-in-2023/
Bevz, R. “Future of pharma & life sciences: What to expect in 2023“. https://www.avenga.com/magazine/pharmaceutical-industry-trends/?region=ua

 FOR AUTHORS

License Contract

Conditions of Publication

Article Requirements

Regulations on Peer-Reviewing

Publication Contract

Current Issue

Frequently asked questions

 INFORMATION

The Plan of Scientific Conferences


 OUR PARTNERS


Journal «The Problems of Economy»

  © Business Inform, 1992 - 2024 The site and its metadata are licensed under CC BY-SA. Write to webmaster